Tuesday, April 30, 2019

FDA Statement on the agency’s list of known nitrosamine-free valsartan and ARB class medicines, as part of agency’s ongoing efforts to resolve ongoing safety issue - FDA Press Releases

FDA announces list of nitrosamine-free ARB medications confirmed by the agency to help patients and healthcare providers

from FDA Press Releases RSS Feed http://bit.ly/2DHObcm
via IFTTT

No comments:

Post a Comment